Health · 1 views

Inhibiting protein to treat myeloproliferative neoplasms shows preclinical promise

Inhibiting menin, a protein that supports leukemia growth and is already targeted to treat some forms of leukemia, also holds promise for…

Source Medical Xpress AI Summary Updated 1h 26m ago

Story intelligence Beta

Freshness Fresh Updated 1h 26m ago

Confidence Limited Single-outlet story

Coverage Single outlet

Views 1 Community interest

Read time 1 min ~50 words

AI Summary

Inhibiting menin, a protein that supports leukemia growth and is already targeted to treat some forms of leukemia, also holds promise for treating myeloproliferative neoplasms. A new study from scientists at St. Jude Children's Research Hospital showed that inhibiting menin significantly extended survival and reversed multiple disease features in preclinica…

Read full article on Medicalxpress

AI summaries can be wrong sometimes—always verify important details using the source article.

SUPPORT HAPPENINGNOW · Independent AI News Intelligence

SUPPORTER MESSAGE

Enjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.

Support HappeningNow

HAPPENING NOW

Inhibiting protein to treat myeloproliferative neoplasms shows preclinical promise

More from Health